Azacitidine recalls
Azacitidine products have been recalled 4 times, most recently on 17 Aug 2022. The recalling company is usually Dr. Reddy's Laboratories. The most common reason is potency & assay.
Total recalls4since 2020
Last 12 months0reported
Class I00% of total
Ongoing0latest 17 Aug 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 25%Class III 3 75%
Why azacitidine is recalled
Companies
Product types
By year
All azacitidine recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Azacitidine for Injection 100mg/vial Lyophilized Powder recalledAzacitidine | Teva Pharmaceuticals USA | Potency & Assay | OH |
| Drug | CLASS III | Azacitidine, 100mg/vial, One Single-dose Vial recalledAzacitidine | Dr. Reddy's Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS III | Azacitidine, 1,00mg/Vial, One Single-dose Vial recalledAzacitidine | Dr. Reddy's Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | Azacitidine for Injection 100 mg/vial, For Subcutaneous recalledAzacitidine | Shilpa Medicare | Manufacturing (CGMP) Deviations | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.